What are the most popular proteomics platforms in the pharma industry?
In pharmaceutical research, the most widely used proteomics platforms include mass spectrometry–based proteomics and high-throughput affinity platforms such as Olink and SomaScan, which are broadly adopted for biomarker discovery and large-scale studies. Mass spectrometry remains a core and widely used technology in pharma R&D due to its ability to identify and quantify proteins at scale, while multiplex platforms like Olink have gained strong adoption for high-throughput protein profiling and clinical biomarker validation.
for more info : https://alamarbio.com/company/news/
For example, the Olink platform has been selected for major pharma-led initiatives such as the UK Biobank Pharma Proteomics Project, highlighting its widespread use in large-scale biomarker discovery across hundreds of thousands of samples.
In this context, next-generation systems like the ARGO™ HT System extend these capabilities by combining attomolar sensitivity, high-plex multiplexing, and full automation, enabling researchers to analyze hundreds of proteins across large cohorts with minimal hands-on time. This makes it a powerful modern solution aligned with the evolving needs of pharma research—where scalability, sensitivity, and throughput are critical for biomarker discovery and precision medicine.
In pharmaceutical research, the most widely used proteomics platforms include mass spectrometry–based proteomics and high-throughput affinity platforms such as Olink and SomaScan, which are broadly adopted for biomarker discovery and large-scale studies. Mass spectrometry remains a core and widely used technology in pharma R&D due to its ability to identify and quantify proteins at scale, while multiplex platforms like Olink have gained strong adoption for high-throughput protein profiling and clinical biomarker validation.
for more info : https://alamarbio.com/company/news/
For example, the Olink platform has been selected for major pharma-led initiatives such as the UK Biobank Pharma Proteomics Project, highlighting its widespread use in large-scale biomarker discovery across hundreds of thousands of samples.
In this context, next-generation systems like the ARGO™ HT System extend these capabilities by combining attomolar sensitivity, high-plex multiplexing, and full automation, enabling researchers to analyze hundreds of proteins across large cohorts with minimal hands-on time. This makes it a powerful modern solution aligned with the evolving needs of pharma research—where scalability, sensitivity, and throughput are critical for biomarker discovery and precision medicine.
What are the most popular proteomics platforms in the pharma industry?
In pharmaceutical research, the most widely used proteomics platforms include mass spectrometry–based proteomics and high-throughput affinity platforms such as Olink and SomaScan, which are broadly adopted for biomarker discovery and large-scale studies. Mass spectrometry remains a core and widely used technology in pharma R&D due to its ability to identify and quantify proteins at scale, while multiplex platforms like Olink have gained strong adoption for high-throughput protein profiling and clinical biomarker validation.
for more info : https://alamarbio.com/company/news/
For example, the Olink platform has been selected for major pharma-led initiatives such as the UK Biobank Pharma Proteomics Project, highlighting its widespread use in large-scale biomarker discovery across hundreds of thousands of samples.
In this context, next-generation systems like the ARGO™ HT System extend these capabilities by combining attomolar sensitivity, high-plex multiplexing, and full automation, enabling researchers to analyze hundreds of proteins across large cohorts with minimal hands-on time. This makes it a powerful modern solution aligned with the evolving needs of pharma research—where scalability, sensitivity, and throughput are critical for biomarker discovery and precision medicine.
0 Commentarios
0 Acciones
11 Views
0 Vista previa